Angehagen M, Ronnback L, Hansson E, Ben-Menachem E. Topiramate reduces AMPA-induced Ca(2+) transients and inhibits GluR1 subunit phosphorylation in astrocytes from primary cultures. J Neurochem. 2005;94(4):1124–30.
Article
PubMed
CAS
Google Scholar
Mirza NS, Alfirevic A, Jorgensen A, Marson AG, Pirmohamed M. Metabolic acidosis with topiramate and zonisamide: an assessment of its severity and predictors. Pharmacogenet Genomics. 2011;21(5):297–302.
Article
CAS
PubMed
Google Scholar
Panday VA, Rhee DJ. Review of sulfonamide-induced acute myopia and acute bilateral angle-closure glaucoma. Compr Ophthalmol Update. 2007;8(5):271–6.
PubMed
Google Scholar
Christensen J, Hojskov CS, Dam M, Poulsen JH. Plasma concentration of topiramate correlates with cerebrospinal fluid concentration. Ther Drug Monit. 2001;23(5):529–35.
Article
CAS
PubMed
Google Scholar
Perucca E. A pharmacological and clinical review on topiramate, a new antiepileptic drug. Pharmacol Res. 1997;35(4):241–56.
Article
CAS
PubMed
Google Scholar
Ramadan NM, Buchanan TM. New and future migraine therapy. Pharmacol Ther. 2006;112(1):199–212.
Article
CAS
PubMed
Google Scholar
Mula M, Cavanna AE, Monaco F. Psychopharmacology of topiramate: from epilepsy to bipolar disorder. Neuropsychiatr Dis Treat. 2006;2(4):475–88.
Article
CAS
PubMed
PubMed Central
Google Scholar
Berlin HA. Antiepileptic drugs for the treatment of post-traumatic stress disorder. Curr Psychiatry Rep. 2007;9(4):291–300.
Article
PubMed
Google Scholar
McElroy SL, Guerdjikova AI, Martens B, Keck PE Jr, Pope HG, Hudson JI. Role of antiepileptic drugs in the management of eating disorders. CNS Drugs. 2009;23(2):139–56.
Article
CAS
PubMed
Google Scholar
Celebisoy N, Gokcay F, Sirin H, Akyurekli O. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand. 2007;116(5):322–7.
Article
CAS
PubMed
Google Scholar
Leblhuber F, Steiner K. Topiramate treatment of essential tremor in a patient with cognitive deficits. Case Rep Neurol. 2010;2(1):1–4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wisniewski M, Lukasik-Glebocka M, Anand JS. Acute topiramate overdose--clinical manifestations. Clin Toxicol (Phila). 2009;47(4):317–20.
Article
CAS
PubMed
Google Scholar
Abtahi MA, Abtahi SH, Fazel F, Roomizadeh P, Etemadifar M, Jenab K, et al. Topiramate and the vision: a systematic review. Clin Ophthalmol. 2012;6:117–31.
Article
CAS
PubMed
PubMed Central
Google Scholar
Leung DY, Leung H, Baig N, Kwan P, Kwong YY, Wong KS, et al. Topiramate and asymptomatic ocular angle narrowing: a prospective pilot study. Eye (Lond). 2009;23(11):2079–81.
Article
CAS
PubMed
Google Scholar
Gok M, Ozdemir O. Effect of topiramate on choroidal thickness and anterior chamber parameters in the treatment of patients with migraine. Cutan Ocul Toxicol. 2017;36(4):381–6.
Article
CAS
PubMed
Google Scholar
Karalezli A, Koktekir BE, Celik G. Topiramate-induced changes in anterior chamber angle and choroidal thickness. Eye Contact Lens. 2016;42(2):120–3.
Article
PubMed
Google Scholar
Hesami O, Hosseini SS, Kazemi N, Hosseini-Zijoud SM, Moghaddam NB, Assarzadegan F, et al. Evaluation of ocular side effects in the patients on topiramate therapy for control of migrainous headache. J Clin Diagn Res. 2016;10(3):NC01–4.
CAS
PubMed
PubMed Central
Google Scholar
Agarwal A. Ciliochoroidal effusion in topiramate-induced bilateral acute angle closure glaucoma. Indian J Ophthalmol. 2019;67(9):1466–7.
Article
PubMed
PubMed Central
Google Scholar
Czyz CN, Clark CM, Justice JD, Pokabla MJ, Weber PA. Delayed topiramate-induced bilateral angle-closure glaucoma. J Glaucoma. 2014;23(8):577–8.
Article
PubMed
Google Scholar
Joshi AK, Pathak AH, Patwardhan SD, Kulkarni AN. A rare case of topiramate induced secondary acute angle closure glaucoma. J Clin Diagn Res. 2017;11(6):ND01–ND3.
PubMed
PubMed Central
Google Scholar
Lam L, Wang N, Ormonde S, Merriman M. Topiramate-induced secondary angle closure: salient points in management. Clin Exp Optom. 2018;101(5):704–6.
Article
PubMed
Google Scholar
Lan YW, Hsieh JW. Bilateral acute angle closure glaucoma and myopic shift by topiramate-induced ciliochoroidal effusion: case report and literature review. Int Ophthalmol. 2018;38(6):2639–48.
Article
PubMed
Google Scholar
Mahendradas P, Parab S, Sasikumar R, Kawali A, Shetty BK. Topiramate-induced acute angle closure with severe panuveitis: a challenging case report. Indian J Ophthalmol. 2018;66(9):1342–4.
Article
PubMed
PubMed Central
Google Scholar
Osaba M, Reviglio VE. Case report: the role of OCT in examination of a patient with topiramate-induced acute angle closure, acute myopia and macular striae. Oxf Med Case Reports. 2018;2018(7):omy030.
Article
PubMed
PubMed Central
Google Scholar
Sierra-Rodriguez MA, Rodriguez-Vicente L, Chavarri-Garcia JJ, Del Rio-Mayor JL. Acute narrow-angle glaucoma induced by topiramate with acute myopia and macular striae: A case report. Arch Soc Esp Oftalmol. 2019;94(3):130–3.
Article
CAS
PubMed
Google Scholar
Sen HA, O'Halloran HS, Lee WB. Case reports and small case series: topiramate-induced acute myopia and retinal striae. Arch Ophthalmol. 2001;119(5):775–7.
CAS
PubMed
Google Scholar
Craig JE, Ong TJ, Louis DL, Wells JM. Mechanism of topiramate-induced acute-onset myopia and angle closure glaucoma. Am J Ophthalmol. 2004;137(1):193–5.
Article
PubMed
Google Scholar
Ikeda N, Ikeda T, Nagata M, Mimura O. Ciliochoroidal effusion syndrome induced by sulfa derivatives. Arch Ophthalmol. 2002;120(12):1775.
Article
PubMed
Google Scholar